A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease.
International Journal of Cancer.
Times cited: 12
Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development.
Cancer Epidemiology Biomarkers and Prevention.
Times cited: 64
Insights from AR gene mutations.
Times cited: 4
Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation.
Molecular Cancer Therapeutics.
Times cited: 72